Vive receives OBIO funding

Vive receives funding from the Ontario Bioscience Innovation Organization (OBIO®).

Vive recently received funding from the Ontario Bioscience Innovation Organization (OBIO®) as part of its Business Skills Development Program (BDSP™). BDSP™ funding was provided to build and enhance Vive’s critical in-house capabilities through mentorship and training of key team members to increase business development efforts, as Vive continues to commercialize and grow the team.

According to Darren Anderson, CEO of Vive, “The support we have received from OBIO® is helping Vive to successfully scale our business, as we plan for rapid growth in our chemistry and biological product portfolios over the next few years.”

Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health science companies positioning Ontario as a leader in the international marketplace. OBIO® advances this goal through collaborative partnerships with industry, the investment community, academia, patients, and government.

For more information on OBIO®, click here:

OBIO® and the Government of Ontario or its agencies are in no way bound by any recommendations contained in this document.